Key facts
- This page summarizes Matthew Charles McMurdo's Form 3 filing for Indaptus Therapeutics, Inc. (INDP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 26 Feb 2026, 10:57.
Matthew Charles McMurdo - 26 Feb 2026 Form 3 Insider Report for Indaptus Therapeutics, Inc. (INDP)
- Reporting relationship
- Director
- Issuer ticker
- INDP
- Reported as of
- 26 Feb 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 26 Feb 2026, 10:57:10 UTC
- Prior SEC filing
- 01 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew McMurdo
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Matthew Charles McMurdo filed Form 3 for Indaptus Therapeutics, Inc. (INDP) on 26 Feb 2026.
Change
- Previous filing in this sequence was filed on 01 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001943108
Primary reporting owner
McMurdo Matthew Charles
- Relationship
- Director
- Address
- C/O INDAPTUS THERAPEUTICS, INC., 3 COLUMBUS CIRCLE 15TH FLOOR, NEW YORK
- Signature
- /s/ Matthew McMurdo
- Signature date
- 26 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INDP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,000
- Date
- 26 Feb 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.